News for '-dr-reddys-lab'

Dr Reddy's sued for patent 'infringement'

Dr Reddy's sued for patent 'infringement'

Rediff.com19 Jun 2013

The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.

Sensex up 44 points at 13,469

Sensex up 44 points at 13,469

Rediff.com15 Nov 2006

The markets opened in the positive terrain after seeing a flat close yesterday

Reddy's get US FDA nod for drug

Reddy's get US FDA nod for drug

Rediff.com10 Jul 2003

24 SEZ developers seek more time for projects

24 SEZ developers seek more time for projects

Rediff.com16 Jan 2014

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Ask Ajit: 'New to investing. Need help'

Ask Ajit: 'New to investing. Need help'

Rediff.com9 May 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex soars 84 points at close

Sensex soars 84 points at close

Rediff.com5 Aug 2004

The BSE Sensex opened with a positive gap of 10 points at 5,179. Fresh buying in the markets led the index spurt to a high of 5,204. The index is now at 5,195, up 26 points. The Nifty is up 7 points at 1,634.

Party continues at D-Street; Sensex clocks 1,600 points in 3 days

Party continues at D-Street; Sensex clocks 1,600 points in 3 days

Rediff.com3 Mar 2016

The S&P BSE Sensex surged 364 points to end at 24,607 and the Nifty50 soared 107 points to close at 7,476.

Sensex tanks 630 points; land, tax reform worries hurt sentiment

Sensex tanks 630 points; land, tax reform worries hurt sentiment

Rediff.com12 May 2015

Markets closed in the red on domestic worries.

Cyclical stocks to lead India Inc's earnings growth in fourth quarter

Cyclical stocks to lead India Inc's earnings growth in fourth quarter

Rediff.com16 Apr 2021

The earnings are, however, expected to be down around 2 per cent on a sequential basis due to pent-up demand getting exhausted and the adverse impact of rising metals and energy prices on consumer goods and manufacturing companies.

Sensex closes flat on special trading day

Sensex closes flat on special trading day

Rediff.com22 Mar 2014

In a range-bound trading, the BSE benchmark Sensex ended a shade higher by 1.57 points in the special 90-minute trading today as funds refrained from making any major commitments in the absence of global cues.

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Rediff.com12 May 2015

Investors lost Rs 2 trillion as Sensex crashed on Tuesday.

Vaccination for COVID-19 will be voluntary: Govt

Vaccination for COVID-19 will be voluntary: Govt

Rediff.com18 Dec 2020

The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

Markets end in green amid volatile trade

Markets end in green amid volatile trade

Rediff.com22 Mar 2016

Indices reversed all its losses during late trades.

India biggest buyer of Covid vaccine with 1.6 bn doses

India biggest buyer of Covid vaccine with 1.6 bn doses

Rediff.com4 Dec 2020

India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.

Market mayhem: Investors lose Rs 3 lakh crore

Market mayhem: Investors lose Rs 3 lakh crore

Rediff.com11 Feb 2016

Adani Ports, BHEL, Tata Motors, ONGC, Mahindra & Mahindra and Tata Steel were the top losers.

Nifty tops 8,500 to end at highest close since August 2015

Nifty tops 8,500 to end at highest close since August 2015

Rediff.com12 Jul 2016

ICICI Bank was the top Sensex gainer after S&P Global Ratings affirmed its 'BBB-' long-term issue ratings on the senior unsecured bonds.

Sensex ends at record high above 29,000 ahead of ECB move

Sensex ends at record high above 29,000 ahead of ECB move

Rediff.com22 Jan 2015

The 30-share Sensex gained 117 points to end above 29,000 at 29,006 while the 50-share Nifty gained 32 points to close at 8,761.

First-time investor: 'I can afford only low-price stocks'

First-time investor: 'I can afford only low-price stocks'

Rediff.com12 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex slips to over 10-day low on rising inflation, weak rupee

Sensex slips to over 10-day low on rising inflation, weak rupee

Rediff.com16 Jun 2014

Profit-booking and selling pressure on below-normal monsoon forecast, marred sentiments, traders said.

Weakness in global equities take sheen off marktes

Weakness in global equities take sheen off marktes

Rediff.com10 Jun 2016

Traders are closely watching the progress of the monsoon.

How India's top business houses fared in 2015-16

How India's top business houses fared in 2015-16

Rediff.com15 Apr 2016

Consumer businesses come to the rescue of large conglomerates in the midst of a meltdown in commodities.

Sensex in bearish mode; realty, metals shine

Sensex in bearish mode; realty, metals shine

Rediff.com24 Dec 2014

The 30-share Sensex dropped 298 points to end at 27,209 and the 50-share Nifty has lost 93 points to end at 8,174.

After 6 weeks of climb, Sensex takes a plunge

After 6 weeks of climb, Sensex takes a plunge

Rediff.com25 Nov 2014

The 30-share BSE Sensex closed down 162 points at 28,338 and the 50-share Nifty was down 67 points at 8,463.

Markets end flat amid volatile trade

Markets end flat amid volatile trade

Rediff.com17 Sep 2013

Markets ended flat on Tuesday, amid a volatile trading session, as investors exercised caution ahead of the two-day FOMC meet starting today and Reserve Bank of India's monetary policy later this week.

Markets continue to trade flat

Markets continue to trade flat

Rediff.com28 Jan 2016

Market breadth was weak with 1239 losers and 1078 gainers on the BSE.

Sensex hits 28K; Nifty ends at 52-week high on GST hopes

Sensex hits 28K; Nifty ends at 52-week high on GST hopes

Rediff.com25 Jul 2016

Financial shares were among the top gainers with HDFC leading the gains.

Markets end flat amid volatile trade; Lupin up 6%

Markets end flat amid volatile trade; Lupin up 6%

Rediff.com7 Jul 2016

Pharma shares were the top gainers led by Lupin after the company received EIR from USFDA for its Goa facility

Nifty ends at 8-month closing high on F&O expiry

Nifty ends at 8-month closing high on F&O expiry

Rediff.com30 Jun 2016

Financial shares were among the top Sensex gainers along with auto and pharma shares.

ASK AJIT: Stocks to hold or exit

ASK AJIT: Stocks to hold or exit

Rediff.com8 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex ends in the green; L&T up 1%, Sun Pharma up 2.9%

Sensex ends in the green; L&T up 1%, Sun Pharma up 2.9%

Rediff.com16 Jan 2015

The 30-share Sensex provisionally ended up 46 points to end at 28,122 and the 50-share Nifty gained 20 points to close at 8,514.

Pharma firms to be hit as drug regulator caps prices

Pharma firms to be hit as drug regulator caps prices

Rediff.com19 Sep 2014

Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share

Markets end lower on uncertainty over UK referendum outcome

Markets end lower on uncertainty over UK referendum outcome

Rediff.com22 Jun 2016

Textile and telecom shares have gained ahead of the Cabinet meet later today which is likely to announce new measures for both the sectors.

Sensex ends 257 points lower on weak global cues; Infosys dips 4%

Sensex ends 257 points lower on weak global cues; Infosys dips 4%

Rediff.com9 Jun 2016

Infosys was the top Sensex loser along with other index heavyweights ITC and HDFC.

Sensex, Nifty underperform global indices; services PMI disappoint

Sensex, Nifty underperform global indices; services PMI disappoint

Rediff.com3 Jun 2016

Investors indulged in profit booking at attractive and higher valuations

Markets end flat amid volatility; Infosys up 3%

Markets end flat amid volatility; Infosys up 3%

Rediff.com27 Mar 2015

The 30-share Sensex ended up 1 point at 27,459 and the 50-share Nifty ended down 1 point at 8,341.

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

Markets end in green; auto, capital goods, realty shine

Markets end in green; auto, capital goods, realty shine

Rediff.com12 Feb 2015

The 30-share Sensex gained 271 points to end at 28,805 and the 50-share Nifty ended up 84 points at 8,712.

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Rediff.com11 Mar 2015

Dilip Shanghvi founded Sun Pharma in 1983.